ArticleExploration (Beijing, China)2024
Models of light absorption enhancement in perovskite solar cells by plasmonic nanoparticles.
Article in Exploration (Beijing, China), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A dielectric SiORSC advances · 2026Article
- Synergistic Effects of MHD Dynamics and Oxygen Vacancies on Electrode Polarization in Photoelectrocatalysis COExploration (Beijing, China) · 2025Article
- How to Select Each Component of COExploration (Beijing, China) · 2025Review
- Tailoring Crystal Growth Regulation and Dual Passivation for Air-Processed Efficient Perovskite Solar Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Hydrovoltaic Power Generation Depend on Wettability at the Liquid-Solid Interface: Mechanisms, Materials, and Applications With Various Resource.Exploration (Beijing, China) · 2025Review
- Frontier applications of retinal nanomedicine: progress, challenges and perspectives.Journal of nanobiotechnology · 2025Review
- Enhancing photovoltaic efficiency in Half-Tandem MAPbIScientific reports · 2025Article
- Regulating the size of antimony nanoparticles to enhance the photo-response in the near-infrared region and anti-hepatoma cell activity.Frontiers in bioengineering and biotechnology · 2025Article
- Models of light absorption enhancement in perovskite solar cells by plasmonic nanoparticles.Exploration (Beijing, China) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Numerous experiments have demonstrated improvements on the efficiency of perovskite solar cells by introducing plasmonic nanoparticles, however, the underlying mechanisms are still not clear: the particles may enhance light absorption and scattering, as well as charge separation and transfer, or the perovskite's crystalline quality. Eventually, it can still be debated whether unambiguous plasmonic increase of light absorption has indeed been achieved. Here, various optical models are employed to provide a physical understanding of the relevant parameters in plasmonic perovskite cells and the conditions under which light absorption may be enhanced by plasmonic mechanisms. By applying the recent generalized Mie theory to gold nanospheres in perovskite, it is shown that their plasmon resonance is conveniently located in the 650-800 nm wavelength range, where absorption enhancement is most needed. It is evaluated for which active layer thickness and nanoparticle concentration a significant enhancement can be expected. Finally, the experimental literature on plasmonic perovskite solar cells is analyzed in light of this theoretical description. It is estimated that only a tiny portion of these reports can be associated with light absorption and point out the importance of reporting the perovskite thickness and nanoparticle concentration in order to assess the presence of plasmonic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.